Arca
Skip to content
Tools
Tools

Mitsar-EEG

Full-Montage Standard Electroencephalograph. 510(k) K143233, from Mitsar Co., Ltd. (St. Petersburg, RU). Product code GWQ, class 2.

As of Nov 18, 2026, K143233 is an FDA 510(k) held by Mitsar Co., Ltd., substantially equivalent on Aug 13, 2015 after 276 days, with no recalls tied to it in FDA's recall database.

  • Review time: 276 days
  • Recalls: 0
  • Cited as a predicate by: 5 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The Mitsar-EEG is intended to acquire, display and store the electrical activity of a patient's brain obtained by placing two or more electrodes on the head to aid in diagnosis.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

5 later 510(k) summaries name this device as a predicate

Other GWQ clearances

The newest 510(k)s for the same product code; their median review was 182 days; see every GWQ device

Record

Type
Traditional
Received
Nov 10, 2014
Review panel
Neurology
Regulation
21 CFR 882.1400

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.